Adicet Bio completes last patient visit for prula-cel study
Adicet Bio says last patient visit is complete for planned analysis of prula-cel in systemic lupus erythematosus, with or without lupus nephritis, and provides a corporate update.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.